Newlink Genetics reported $-7720000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US $ -48.32M 17.19M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M
Intrexon XON:US $ -19.25M 5.78M
Merk MRK:US $ 4310M 552M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Newlink Genetics NLNK:US $ -7.72M 2.08M
Pfizer PFE:US $ 7863M 4470M
Prothena PRTA:US $ -36.29M 3.11M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Vascular Biogenics VBLT:US -10428000 1.32M
YTE INCY:US $ 37.99M 525.86M